Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CeQur: Conforming to the Lifestyle of the Type 2

This article was originally published in Start Up

Executive Summary

Insulin delivery devices don't fit into the lifestyles of patients with type 2 diabetes so they don't comply with their prescriptions. As a result, patients don't feel as well as they could today and down the road face the complications of poorly controlled diabetes. CeQur hopes to offer patients with diabetes a simple, inconspicuous and disposable patch pump that they can stick on the body. There will be no complicated programming or instructions--they'll simply dispense insulin at the touch of a button. (This article is a side bar to "Will Simpler Devices Tap the Largest Diabetes Market?" Start-Up, November 2008. )

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel